Monogram Orthopaedics, Inc.
NasdaqCM MGRM
Monogram Orthopaedics, Inc. Price to Sales Ratio (P/S) on January 14, 2025: 232.20
-
Monogram Orthopaedics, Inc. 52-week high Price to Sales Ratio (P/S) is 372.10 on April 11, 2024, which is 60.25% above the current Price to Sales Ratio (P/S).
-
Monogram Orthopaedics, Inc. 52-week low Price to Sales Ratio (P/S) is 152.68 on March 20, 2024, which is -34.25% below the current Price to Sales Ratio (P/S).
-
Monogram Orthopaedics, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 228.27.
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
| CEO | Mr. Benjamin Sexson C.F.A. |
| IPO Date | May 18, 2023 |
| Location | United States |
| Headquarters | 3913 Todd Lane |
| Employees | 28 |
| Sector | Technology |
| Industries | |
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email